Autoliv, Inc. (NYSE:ALV) reported Q1 EPS of $1.43, in-line with the analyst estimate of $1.43. Revenue for the quarter came in at $2.3 billion versus the consensus estimate of $2.3 billion. Autoliv Inc. (NYSE:ALV) shares after opening at $102.55 moved to $103.25 on last trade day and at the end of the day closed at $101.32 . Company price to sales ratio in past twelve months was calculated as 1.08 and price to cash ratio as 8.51. Autoliv Inc. (NYSE:ALV) showed a negative weekly performance of -1.26%.
Abengoa, S.A. – American Depositary Shares (NASDAQ:ABGB)‘s stock had its “” rating reiterated by equities research analysts at Canaccord Genuity in a research note issued to investors on Friday, AnalystRatings.Net reports. They currently have a $28.00 price target on the stock. Canaccord Genuity’s price target would indicate a potential upside of 19.66% from the company’s current price. Abengoa, S.A. – American Depositary Shares (NASDAQ:ABGB) shares fell -1.69% in last trading session and ended the day on $22.16.
Escalon Medical Corp (NASDAQ:ESMC) announced that it has entered into a distribution agreement with Long Beach, NY based BiCOM Inc., to distribute its transpalpebral “Diaton” tonometer. The Diaton tonometer will be featured alongside the Company’s new VuPad™ ultrasound system at the Annual Symposium and Congress of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston, April 25-29 (booth 873). Escalon Medical Corp. (NASDAQ:ESMC) was closed at $1.57 while trading in range of $1.49 – $1.63 – Escalon Medical Corp. (NASDAQ:ESMC) year to date (YTD) performance is -20.30%.
ANADIGICS, Inc. (Nasdaq:ANAD), a leading provider of semiconductor solutions in the broadband wireless and wireline communications markets, announced that it will release its first quarter results on April 30, 2014 at approximately 4:00 pm Eastern Time. ANADIGICS, Inc. (NASDAQ:ANAD) weekly performance is -4.86%. On last trading day company shares ended up $1.37. ANADIGICS, Inc. (NASDAQ:ANAD) distance from 50-day simple moving average (SMA50) is -21.53%. Analysts mean target price for the company is $2.36.